Pharmaceutical & Biotech ROW articles
- Making Early Access Real, getting treatments to patients with no other option, Therapeutics - Jan 2011
File size - 131KB - The specifics of early access programmes, Pharmafocus - Dec 2010
File size - 225KB - Contrasting approaches to early access across the globe,
Pharmafocus - Dec 2010
File size - 53KB - Why Provide Early Market Access? www.samedanltd.com - Dec 2010
File size - 770KB - Need for speed. Accelerating access to drugs for orphan diseases benefits patients and industry, by Simon Estcourt. - Nov 2010
File size - 119KB - Putting Early Access On The Radar: Peter Mansell talks to Simon Estcourt about Idis' expertise in early market access and innovating the pharma and biotech model, PharmaTimes - Apr 2010
File size - 1.1MB - Benefits of pre-launch access: An overview by Natalie Douglas, CEO Idis - Jan 2009
File size - 4.2MB - The Journal of Life Sciences - Aug 2008
File size - 588KB - Meeting Unmet Needs: An overview by Natalie Douglas, CEO Idis - Apr 2008
File size - 1.3MB
